[Tree] Partnership for drug discovery using AI platform
Version 0.1 (2024-03-15 12:32:11.002000)
updates: West Virginia partners with GATC for drug discovery
- ➔
Version 0.09 (2024-03-14 09:44:25.667000)
updates: Introduction of Partex NV collaboration with Sanofi for AI-based dossier enrichment
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.08 (2024-03-10 12:02:42.500000)
updates: Addition of information about Synexty and DeepMinds collaboration to launch Vitalls.AI
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.07 (2024-02-28 20:44:06.890000)
updates: Inclusion of information about the major donations received by the Université de Moncton for AI in health research
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.06 (2024-02-19 10:40:55.626000)
updates: Addition of information about GlycanAge's seed funding and its focus on personalized healthcare diagnostics
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.05 (2024-02-16 16:35:31.542000)
updates: Inclusion of Innovate UK grant for AI-VISION breast cancer project
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.04 (2024-02-14 12:56:10.494000)
updates: Integration of AI-driven drug discovery by CytoReason
- ➔
- ➔
- ➔
- ➔
Version 0.03 (2024-01-18 09:55:54.309000)
updates: New information about CellVoyant securing £7.6M in seed funding for stem cell therapy AI
- ➔
- ➔
- ➔
Version 0.02 (2023-11-29 15:45:09.890000)
updates: The Longevity Forum launches the Longevity Science Prize to address the health needs of ageing societies.
- ➔
- ➔
- ➔
- ➔
Version 0.01 (2023-11-25 15:31:19.129000)
updates: Integration of Generation Z's role in philanthropy
- ➔
- ➔
- ➔